Follow our progress.

Invitae’s platform demonstrates high concordance with traditional diagnostic tests for BRCA1 and BRCA2 and increased yield of clinical findings in hereditary cancer risk assessment.

SAN ANTONIO – December 10, 2014 – Invitae Corporation, a genetic information company, announced the presentation of two scientific studies at the 37th Annual San Antonio Breast Cancer Symposium: “Clinical Evaluation of Multi-gene Testing for Hereditary Breast and Ovarian Cancer” (Poster P4-12-04) and “Technical Evaluation of Multi-gene Testing for Heredity Breast and Ovarian Cancer” (Poster P4-12-07).  

The studies ...

SAN FRANCISCO, December 3, 2014 – Invitae Corporation, a genetic information company, announced that its testing services are eligible for coverage by two additional payors, Blue Shield of California and the Centers for Medicare and Medicaid Services (CMS). 

“Securing reimbursement is an important step towards realizing our mission to make genetic testing affordable and accessible for patients,” said Lisa Alderson, chief commercial officer of Invitae.  “Since launching just over a year ago, we have grown our volume rapidly by offering high ...

SAN FRANCISCO, December 2, 2014 – Invitae Corporation, a genetic information company, announced that it has received accreditation from the College of American Pathologists (CAP). 

The CAP accreditation is awarded to facilities that meet the highest standards of quality in laboratory services. According to the Commission on Laboratory Accreditation, the U.S. government recognizes the CAP Laboratory Accreditation Program, which began in the early 1960s, as being equal-to or more-stringent-than the government’s own inspection program. 

During the CAP accreditation process, inspectors ...

SAN FRANCISCO, October 13, 2014 – Invitae Corporation, a genetic information company, today announced the completion of a $120 million Series F financing. Invitae plans to use the proceeds to accelerate the build out of its infrastructure for its genetic information business, as well as to expand its global presence. 

New investors participating in the round included (in alphabetical order) The Broe Group, Decheng Capital, Deerfield Management LLC, OrbiMed, Perceptive Advisors, Rock Springs Capital and Wellington Management Company, LLP, among ...

SAN FRANCISCO - August 12, 2014 - Invitae Corporation, a genetic information company, offers PALB2 testing, providing clinicians with a reliable, fast and affordable option for their cancer patients. Available with a turnaround time of approximately three weeks, the test includes full gene sequencing and deletion/duplication analysis. The test is globally available and is priced at $1,500 in the United States.

A recent multinational study provides compelling evidence that PALB2 is a high-risk breast cancer susceptibility gene (Antoniu et al, ...

-- Partnership Expands Invitae’s Global Presence into Mexico, Costa Rica, & Panama --

SAN FRANCISCO and MEXICO CITY― July 30, 2014 ― Invitae Corporation, a genetic information company, and Nanopharmacia, the leading oncology molecular test provider in Mexico, today announced an exclusive partnership to make Invitae’s genetic tests for the management of hereditary cancers broadly available throughout Mexico.  In addition, the partnership includes access on a non-exclusive basis in Costa Rica and Panama. 

Nanopharmacia will offer Invitae’s hereditary cancer panels ...

SAN FRANCISCO, June 12, 2014 – Invitae Corporation, a genetic information company, today announced that it now offers multi-gene testing for hereditary pancreatic cancer, providing clinicians with a reliable, fast and affordable option for their cancer patients and their families. With results typically available within three weeks, this panel includes an analysis of 17 genes and currently is the most comprehensive panel available. The test is available globally and at a contracted price of $1,500 in the United States. 

The ...

SAN FRANCISCO, January 13, 2014 – Invitae Corporation, a diagnostic genetic information company, today announced that the “Invitae Family History Tool” is now available.  It is a free family history collection app that enables genetic counselors to digitally build, modify, share, and save their patients’ pedigrees.  Available as an iPad and a web app, both versions can be accessed by visiting www.invitae.com/en/family-history/ or by downloading the iPad app directly from Apple’s App Store.

The Invitae Family History ...

Panel Titled, “Supreme Court Strikes Down Patents on Human Genes: Implications for Industry, Pricing & Personalized Medicine”

SAN FRANCISCO, January 10, 2014 – Invitae Corporation, a genetic diagnostics company, today announced that Sean George, co-founder of Invitae, is scheduled to speak on a panel titled, “Supreme Court Strikes Down Patents on Human Genes: Implications for Industry, Pricing & Personalized Medicine” during the 32nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2014 at 5:00 pm PST in San ...